Lazard Asset Management LLC Global Blood Therapeutics, Inc. Transaction History

Lazard Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $58,806 - $123,746	1,815 New	1,815 $123,000
Q2 2022 Aug 09, 2022	SELL	$22.3 - $37.39 $57,511 - $96,428	-2,579 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$24.9 - $40.26 $15,363 - $24,840	617 Added 31.45%	2,579 $75,000
Q3 2021 Nov 15, 2021	BUY	$25.48 - $37.34 $49,991 - $73,261	1,962 New	1,962 $49,000
Q1 2021 May 14, 2021	SELL	$38.94 - $50.85 $59,928 - $78,258	-1,539 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$37.65 - $63.77 $57,943 - $98,142	1,539 New	1,539 $66,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lazard Asset Management LLC with notifications on news.